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Abstract and Key Words 
Introduction:  Electromagnetic navigation bronchoscopy (ENB)-guided pleural dye marking is useful to 
localize small peripheral pulmonary nodules for sublobar resection.  
Objective: To report findings on the use of ENB-guided dye marking among participants in the 
NAVIGATE study. 
Methods:  NAVIGATE is a prospective, multicenter, global, observational cohort study of ENB use in 
patients with lung lesions. The current subgroup report is a prespecified 1-month interim analysis of 
ENB-guided pleural dye marking in the NAVIGATE United States cohort.  
Results:  The full United States cohort includes 1,215 subjects from 29 sites (April 2015 to August 2016). 
Among those, 23 subjects (24 lesions) from 7 sites underwent dye marking in preparation for surgical 
resection. ENB was conducted for dye marking alone in 9 subjects while 14 underwent dye marking 
concurrent with lung lesion biopsy, lymph node biopsy, and/or fiducial marker placement. The median 
nodule size was 10 mm (range 4-22) and 83.3% were <20 mm in diameter. Most lesions (95.5%) were 
located in the peripheral third of the lung, at a median of 3.0 mm from the pleura. The median ENB-
specific procedure time was 11.5 minutes (range 4-38). The median time from dye marking to resection 
was 0.5 hours (range 0.3-24). Dye marking was adequate for surgical resection in 91.3%. Surgical 
biopsies were malignant in 75% (18/24). 
Conclusion: In this study, ENB-guided dye marking to localize lung lesions for surgery was safe, 
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Introduction 
Lung cancer is common and deadly.1 Lung cancer screening will likely increase the incidence of small 
peripheral lung nodules and ground glass opacities detected by low-dose computed tomography (CT).2 
Surgical resection of these lesions is frequently done for diagnostic and therapeutic purposes. Minimally 
invasive techniques such asrobot-assisted thoracoscopic surgery (RATS) and video-assisted 
thoracoscopic surgery (VATS) allow the surgeon to remove these lesions with a decrease in postoperative 
pain, air leak duration, length of hospital stay, and overall complication rates with equivalent oncologic 
results to traditional open surgery.3-5 However, these methods limit the surgeon’s ability to identify 
lesions using bimanual palpation. This may be particularly challenging when the target nodule is small,
further from the pleura, or predominately ground glass. While wires, fiducial markers, dyes, and 
radiotracers percutaneously placed in or near the target lesion can aid in localization for resection,6-11 
small and non-solid nodules remain a challenge. Additionally, these techniques can be limited when 
performed outside the operating room. Wire dislodgement, widespread dye diffusion by the time of 
surgery, and increased logistic requirements between hospital services may all result in failed localization, 
wider resections, increased conversion to open thoracotomy, or repeat procedures.12 
Electromagnetic navigation bronchoscopy (ENB) allows the surgeon or pulmonologist to mark lung 
lesions in the operating room just prior to the surgery.12,13 This paper reports the findings on the use of 
ENB for pleural dye marking for surgical resection among participants in the NAVIGATE study. The 
objective of this subgroup analysis is to evaluate ENB-guided dye marking usage patterns, techniques, 
and performance in a multicenter experience. Results of ENB-guided fiducial marking in NAVIGATE 
have been previously published.14 
Materials and Methods 
NAVIGATE (www.clinicaltrials.gov, NCT02410837) is a prospective, multicenter, global, single-arm, 
cohort study evaluating ENB procedures.14-17 All ENB procedures used the superDimension™ navigation 
system version 6.0 or higher (Medtronic, Minneapolis, MN). The success rate of dye marking 
demonstrated by successful surgical resection was prespecified as a secondary endpoint of the study. The 
current interim subgroup analysis presents the subset of NAVIGATE subjects from the United States 
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All consecutive, consented adult patients, who were not pregnant or nursing, and who were candidates for 
an elective ENB-guided dye marking procedure based on physician discretion per recommended 
guidelines and institutional standard-of-care, were eligible for enrollment. Subjects could also have 
concurrent lung lesion biopsy, fiducial marker placement, or lymph node biopsy in the same procedure. 
The selection of patients for dye marking procedures, choice of dye, dye marking technique, and all other 
complementary tools and procedures were performed at the operator’s disc etion. These choices were 
intentionally not mandated per protocol in order to provide a real-world multicenter evaluation of ENB 
usage patterns and outcomes. 
Subjects were evaluated at baseline (within 30 days of the procedure), on the procedure day, and at 1 
month post-procedure. For the current subgroup analysis, prospectively captured endpoints included 
subject demographics, medical history, and procedural characteristics (e.g., anesthesia type, concurrent 
imaging, procedure time, type of dye, time from dye placement to surgical resection, and operator-
reported adequacy for surgical resection). Prospectively captured complications included pneumothorax, 
bronchopulmonary hemorrhage, and respiratory failure related to the ENB procedure or devices defined 
according to the validated Common Terminology Criteria for Adverse Events scale and adjudicated by an 
independent medical monitor.15 
Lesion characteristics (e.g., size, location, and morphology) and final diagnoses were prospectively 
captured in NAVIGATE for those lesions undergoing ENB-aided lung lesion biopsy but were not 
specifically captured for lesions undergoing ENB-aided pleural dye marking alone. Thus, lesion 
characteristics and final diagnoses based on surgical biopsy samples for dye marking cases were 
retrospectively captured by the operators using prospectively designed and independently monitored case 
report forms. The number of subjects with data for each variable is reported. 
The ENB procedure and dye marking were conducted according to physician preferences and standard 
site practices. All operators used fluoroscopy during the dye marking procedure. There were slight 
variations by physician (see Online Supporting Information).  
No sample size calculations were conducted for this single-arm, observational subgroup analysis. 
Analyses were performed using SAS® Version 9.4 (SAS Inc., Cary, NC). Data were summarized by 
descriptive statistics, including frequency distributions and cross-tabulations for discrete variables and 
mean, standard deviation, median, minimum, and maximum values for continuous variables. At least 20% 
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This study is being conducted in accordance with the Declaration of Helsinki and all local regulatory 
requirements. The protocol was approved by the institutional review board of all participating clinical 
sites. Written informed consent was obtained for all subjects. 
Results 
Participants 
A total of 1,215 subjects were enrolled in the NAVIGATE United States cohort at 29 clinical sites (April 
2015 - August 2016).17 Among those, 23 subjects (24 lesions) underwent pleural dye marking in 
preparation for surgical resection. Dye marking was conducted at 7 sites by a single operator at each site 
(authors CA, DA, OA, DM, MP, OR, and ES). A range of 1 to 6 subjects was enrolled per operator. 
Subject demographics and medical history are shown in Table 1.  
Lesion Characteristics 
Lesion characteristics are shown in Table 2. The median lung lesion size was 10.0 mm and 83.3% were 
less than 20 mm in diameter. Half of the lesions were in the upper lobes and all but one wasin the 
peripheral third of the lung. Two lesions were ground glass opacities. The median distance from the lesion 
to the pleura was 3.0 mm (range 0-48 mm, Figure 1). A bronchus sign was present on the pre-procedure 
CT scan in 12.5% (3/24). 
ENB Procedural Characteristics 
Of the 23 subjects undergoing ENB-guided pleural dye marking, 9 underwent dye marking alone (without 
lung lesion biopsy or fiducial placement), 1 underwent ENB-guided dye marking and ENB-guided lymph 
node biopsy, 1 underwent dye marking and lung lesion biopsy, 6 underwent dye marking and fiducial 
marker placement, and 6 underwent dye marking, lung lesion biopsy, and fiducial marker placement. 
Subsequent surgical resection was attempted or conducted in all 23 subjects, as will be described below. 
Characteristics of the ENB-guided dye marking procedures are shown in Table 3. General anesthesia was 
used in 22/23 subjects. Fluoroscopy was used during the ENB-guided dye marking procedure in 21 cases, 
and 57.1% of lesions were visible on fluoroscopy. Radial endobronchial ultrasound (EBUS) was used in 
4/23. The total bronchoscopic procedure time was a median of 22.0 minutes. The ENB procedure time 
(first locatable guide / extended working channel entry to last exit) was a median of 11.5 minutes (range 
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Complications 
There were no instances of pneumothorax, bronchopulmonary hemorrhage, respiratory failure, or death 
related to the ENB index procedure or devices among the 23 subjects undergoing dye marking. 
Surgical Procedures and Final Diagnoses 
Surgical resection was attempted in all subjects. The median time from dye marking to surgical resection 
was 30 minutes; surgery occurred within 1 hour of dye marking in all but one case in which it occurred 24 
hours later. 
Pleural dye placed under ENB guidance was visualized and considered adequate for surgical resection by 
the operator in 21/23 cases (91.3%). In one case, surgery occurred 30 minutes after dye marking and the 
thoracic surgeon noted that the methylene blue dye was not visible on the surface of the lung. However, 
concurrent fiducial marker placement in that case allowed confirmation of the lesion location. In the 
second case, an endoscopic dye as well as fiducial markers were placed. Left thoracoscopic upper lobe 
wedge resection, upper division segmentectomy (lingula-sparing), and mediastinal lymph node dissection 
were performed 24 hours after the ENB procedure. While the dye was not visible, the microcoil was 
present. 
Surgical procedures were primarily done by VATS; there was one RATS procedure. Initial surgical 
approaches included 19 wedge resections, 1 segmentectomy, and 2 lobectomies. In two cases, a wedge 
resection confirmed cancer and an open lobectomy was conducted in the same setting. One VATS 
procedure had to be aborted due to extensive adhesions when the patient refused a more invasive 
approach. 
Final diagnoses based on surgical biopsy are shown in Table 4. Among the 24 lesions (23 subjects), 
primary lung cancer was found in 13/24 (12 adenocarcinoma and 1 carcinoid tumor) and 5 were cancers 
of metastatic origin. The remaining 6 lesions were benign (1 chondroid hamartoma, 2 granulomas, and 3 
with non-specific histologic findings). 
Discussion 
We report the findings of the only prospective, multicenter study to date evaluating the utility of ENB-
guided pleural dye marking for surgical resection. Prior to NAVIGATE, all of the previous studies 
concerning preoperative localization for pulmonary nodules by any method have been either retrospective 
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In our cohort there were no procedural complications and the dye marking was considered successful in 
91% (21/23) of the cases. This is consistent with previous reports concerning ENB-guided pleural dye 
marking.12,21-25 In comparison, localization with hookwire and CT-guided dye marking typically has 
success rates of 80-100% but with procedural related complications of 15-50%,9-11,26 higher than observed 
in the current ENB study. Additionally, hookwire dislodgment may result in failure to locate the lesion, 
thus requiring a conversion from a minimally invasive approach to a thoracotomy.6,7,9,11,18 
In the current study, dye marking procedures were performed by 7 ph sicians (4 pulmonologists and 3 
thoracic surgeons). The majority of dye marking procedures were done in the operating room just prior to 
the VATS or RATS, and all of the surgeons completed both the localization and the surgical procedure 
for their cases. One of the participants performed the dye marking procedure under moderate sedation in 
the endoscopy lab either the same day of the surgery or the day before the resection. The median 
bronchoscopy time was 22 minutes, which is faster than some previous studies (range 9.7 to 34.5 
minutes).12 
The median “wait time” from the dye marking procedure to the VATS was 30 minutes in the current 
study. Bolton et al. evaluated ENB-guided dye marking compared to CT-guided hookwire localization in 
117 patients with small peripheral pulmonary nodules undergoing minimally invasive lung surgery. The 
wait time was significantly longer with the CT-guided procedure compared to the ENB method (189 
minutes versus 26 minutes, P<0.001). Both techniques resulted in a 100% success rate and there were no 
conversions to a thoracotomy due to localization failure. A propensity matched analysis of same-day CT-
guided dye marking (30 patients) versus ENB-guided dye marking in the hybrid OR (15 patients) prior to 
VATS found similar localization success rates between the two methods but significantly shorter overall 
time from localization to surgery and a significantly lower pneumothorax rate in the ENB group (6.7% vs. 
36.7%, P=0.03).27 Given our small cohort, we were unable to evaluate if the wait time was shorter when 
localization was performed by the surgeon. However, since the majority of cases were done in the 
operating room under one anesthetic episode just prior to the surgery, it is doubtful that this would have 
impacted the wait time. Further investigation is required to evaluate the maximum operative efficiency 
concerning the timing, location, and impact of the proceduralists related to ENB-guided localization.  
In our study, 7/24 lesions had a biopsy of the target lesion at the same time as the dye marking procedure. 
In 2/7 of these patients, a definitive diagnosis of adenocarcinoma was obtained during the ENB 
procedure, which was confirmed by biopsy of the surgical specimen. A definitive diagnosis from a biopsy 
at the time of the localization procedure may eliminate the need for a diagnostic wedge resection in the 
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therapeutic lobectomy and if a non-malignant diagnosis is made, the patient may not need a surgical 
procedure at all in the appropriate clinical context. If a metastatic lesion is diagnosed, the surgeon may 
immediately proceed to a targeted parenchymal-sparing but oncologically sound resection. The versatility 
of ENB has been regularly reported in the literature.12 Bolton et al. described that in 19 patients with 
pulmonary nodules undergoing ENB-guided dye marking for localization for a diagnostic wedge 
resection, 74% (14/19) had an ENB-directed biopsy at the time of the localization procedure. Twenty-one 
percent (3/14) had a malignant diagnosis from the biopsy, as determined by rapid onsite pathologic 
examination, and avoided the diagnostic wedge resection. These patients were able to proceed directly to 
a therapeutic lobectomy.28 In a more recent study in patients with pulmonary nodules undergoing a 
diagnostic wedge resection, 75% (60/81) had a biopsy at the same time as the ENB-guided dye marking 
procedure. Twenty-seven percent (16/60) had a diagnosis of cancer, which changed the operative 
approach.21 In contrast, in patients undergoing CT-guided hookwire localization, 0/36 had a biopsy in 
which 97% (35/36) had a wedge resection and 1 patient underwent a segmentectomy.21 
While ENB was useful in localizing peripheral lung nodules in this analysis, fluoroscopy was also used in 
most cases and radial EBUS was used in 4 cases. However, the lesion was only visible by fluoroscopy in 
12/21 cases. Radial EBUS has been shown effective for pleural dye marking in a recent study,29 although 
lesion visualization may be challenging when the image is not concentric. The combined method of ENB, 
fluoroscopy, and radial EBUS may be advantageous when indicated and available. 
Despite the safety, accuracy, and versatility of ENB-guided pleural dye marking for localization, it 
seemed to be an underutilized procedure in the NAVIGATE trial. Only 23 subjects out of the 1,215 
subjects enrolled in the United States had a dye marking procedure. This is especially interesting given 
that in the overall NAVIGATE study, 63.6% were of a limited stage, 62.6 % were located in the 
peripheral third of the lung,15 and 6.3% were classified as ground glass.17 Of the 232 biopsy subjects with 
Stage I-II lung cancer in first interim analysis of NAVIGATE16 there were 87 who had a surgical 
procedure and of those, 65 (75%) had no prior ENB-guided dye or fiducial marking. There have been 15 
clinical studies (excluding single-patient case reports) concerning ENB-guided dye localization12,21-24,27 
and only 3 have enrolled over 50 patients.21,30,31 These numbers suggest that perhaps dye marking is not 
underutilized, but rather not needed frequently. Further evaluation is required concerning the need for 
prior localization based on surgical practice patterns. A primary open thoracotomy approach in physicians 
not trained in VATS or RATS, lack of onsite pathology services, or unavailability of interventional 
pulmonology or radiology teams to perform localization may all be contributing factors. The low 
proportion of ground glass lesions in NAVIGATE (6.3%) versus 17% (60/336) in other ENB-guided dye 
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majority of the cases were small solid or sub-solid lesions. This procedure may be particularly useful in 
the era of low-dose computed tomography screening for lung cancer, as we expect to find smaller 
resectable lung lesions. Thus, while not frequently used, ENB-guided dye localization is a safe, 
successful, and efficient tool for the surgeon armamentarium with added benefits for surgical planning 
and parenchyma sparring interventions in the appropriate clinical settings.  
Limitations of the study include a relatively small number of patients evaluated, as noted above, and the 
lack of a comparator group. In addition, the study did not identify why a localization procedure was not 
utilized. While the observational design allows an unrestricted, real-world snapshot of dye-marking 
practice patterns, the study was not designed to validate physician choice in patient selection for dye 
marking, dye marking methodology, or surgical technique. 
Conclusions 
In this multicenter study, ENB-guided dye marking for localization for lung surgery was safe, accurate, 
and versatile. In prior studies, it has been shown to be as successful as other localization techniques with 
fewer complications, and biopsies can be performed at the same time as the dye marking procedure 
Despite the benefits, ENB-guided dye marking in NAVIGATE seems to be an underutilized procedure. 
More information is needed concerning surgeons’ practice patterns, the need for localization, and the 
most efficient method. Identification of these variables will also allow for improved cost analysis and 
implementation protocol recommendations.  
Data Accessibility 
Compiled NAVIGATE data will be made publicly available on ClinicalTrials.gov (NCT02410837) after 
the completion of the two-year follow-up. The interim data on which this paper is based are available 
from the corresponding author upon reasonable request. 
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Table 1.  Demographics and Medical History (n= 23 Subjects Undergoing Dye Marking) 
Age at consent (years) 66.0 [46.0-80.0] (23) 
Female / Male 69.6% / 30.4% 
Tobacco History (Current or Former) 73.9% (17/23) 
Current 17.6% (3/17) 
Former 82.4% (14/17) 
Chronic Obstructive Pulmonary Disease 26.1% (6/23) 
Asthma 26.1% (6/23) 
FEV1 (% of predicted) 104.0 [77.0-127.0] (11) 
DLCO (% of predicted) 82.0 [51.0-128.0] (10) 
Personal History of Cancer 60.9% (14/23) 
Data are presented as % (n/N subjects) or median [range] (N) 
Acronyms:  DLCO:  diffusing capacity of the lung for carbon monoxide; FEV1:  forced expiratory volume 
in 1 second. 
 
Table 2.  Lesion Characteristics (n=24 lesions in 23 subjects) 
Average Lung Lesion Size, mm 10.0 [4.0-22.0] (24) 
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≥ 20 mm 16.7% (4/24) 
Lesion Location  
Right Upper Lobe 25.0% (6/24) 
Right Middle Lobe 4.2% (1/24) 
Right Lower Lobe 29.2% (7/24) 
Left Upper Lobe 25.0% (6/24) 
Left Lower Lobe 16.7% (4/24) 
Lung Zone *  
Peripheral third of lung on CT 95.5% (21/22) 
Middle third of lung on CT 4.5% (1/22) 
Proximal third of lung on CT 0.0% (0/22) 
Lesion Visible on Fluoroscopy 57.1% (12/21)† 
Ground Glass Opacity (Suzuki Class 1 or 2) 9.1% (2/22)† 
Spiculated Lesion Border 50.0% (10/20)† 
Bronchus Sign Present on Pre-Procedure CT 12.5% (3/24) 
Distance from Lesion to Pleura, mm 3.0 [0.0-48.0] (21)† 
Data are presented as % (n/N lesions) or median [range] (N) 
* See Folch et al. 2016 for definitions 15 Missing lung zone data for 2 lesions. 
† Missing fluoroscopy data for 3 lesions, GGO data for 2 lesions, border morphology data for 4 lesions, 
and distance to pleura data for 3 lesions. 
 
 
Table 3.  Procedural Characteristics (n=23 procedures) 
General Anesthesia 95.7% (22/23) 
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ENB Software Version  
Version 6 30.4% (7/23) 
Version 7 69.6% (16/23) 
Radial EBUS used During ENB Procedure* 17.4% (4/23) 
Cone Beam CT used 8.7% (2/23) 
Total Procedure Time (Bronchoscope In / Out), min 22.0 [6.0-167.0] (23) 
ENB Procedure Time (EWC/LG In / Out), min† 11.5 [4.0-38.0] (16) 
Type of dye used   
Methylene Blue 91.3% (21/23) 
Methylene Blue and Omnipaque  4.3% (1/23) 
Other (Spot Endoscopic Marker) 4.3% (1/23) 
Time from dye placement to surgical resection (hours) 0.5 (0.3-24.0) (22) 
Dye marking adequate for subsequent surgical resection 91.3% (21/23) 
Data are presented as % (n/N procedures) or median [range] (N) 
* Other than for lymph node biopsy. 
† Data only available for 16 subjects, because question was added to case report forms after enrollment 
had begun 
Acronyms:  CT: computed tomography; EBUS: endobronchial ultrasound; ENB: electromagnetic 




Table 4.  Final Diagnoses based on Surgical Biopsy (n=24 lesions) 
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Primary Lung Cancer 13/24 
Adenocarcinoma 12/24 
Carcinoid Tumor 1/24 
Metastatic Carcinoma of Extrathoracic Origin * 5/24 
Benign 25% (6/24) 
Chondroid Hamartoma 1/24 
Non-Specific Histologic Findings † 3/24 
Granuloma 2/24 
* Origin:  2 renal, 2 colon, and 1 thigh myxoid spindle cell. 
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